| Financial Year |
March 31 2023 |
| Monetary Funds |
236,530,282.04 |
| Held-for-trading Financial Assets |
170,000,000.00 |
| Notes Receivable |
2,500,755.11 |
| Accounts Receivable |
474,532,635.60 |
| Advances to Suppliers |
41,652,983.17 |
| Other Receivables |
23,464,093.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
202,124,986.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,246,716.57 |
| Total Current Assets |
1,187,835,068.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
30,288,100.15 |
| Investment Properties |
-- |
| Fixed Assetes |
144,908,335.32 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,173,832.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
42,842,172.62 |
| Other Non-Current Assets |
4,801,850.78 |
| Sub-Total of Non-Current Assets |
285,908,067.27 |
| Total Assets |
1,473,743,135.67 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
74,783,187.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,466,478.32 |
| Taxes Payable |
16,575,621.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,520,159.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,221,258.33 |
| Other Current Liabilities |
40,937,833.25 |
| Sub-Total of Current Liabilities |
492,387,760.11 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,375,294.29 |
| Total Liabilities |
523,763,054.40 |
| Paid-In Capital(Or Share Stock) |
270,000,000.00 |
| Capital Surplus |
58,763,411.86 |
| Surplus Reserve |
63,144,259.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
548,800,137.37 |
| Minority Stockholder's Interest |
9,272,272.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
940,707,808.81 |
| Owner's Equity（Stockholder's Equity） |
949,980,081.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,473,743,135.67 |
